Drug-device maker Kaléo has secured a federal contract worth $96.1 million, enlisting in an effort to bolster U.S. biodefense ...
Kaléo, a Glen Allen, Virginia-based drug-delivery device and auto-injector company, announced on October 7, 2026 that it has ...
Base award supports late-stage development, regulatory approval activities, and initial procurement of Kaléo’s next-generation 2-PAM auto-injector for organophosphate and nerve agent poisoning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results